Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

Mr. Enrico Cañal Bruland, General Manager, Novo Nordisk Pharma (Thailand ... support in empowering people with diabetes to lead fulfilling lives, pursue education, careers, and reach their ...

A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

The multi-year collaboration with Novo Nordisk is focused on using genomic information in treating metabolic diseases such as obesity and diabetes ... environment, education and culture-related ...

There's no doubt that self-injection devices have transformed the lives of people with chronic diseases like diabetes ... according to Novo Nordisk. "Up to 85% of the materials in every pen ...

Given its low valuation and the seeming overreaction in the markets to the recent trial results, this is a stock that could ...

Diabetes specialist Novo Nordisk is feeling the heat from increasingly price conscious US payers. It needs next generation innovation and growth in emerging markets to keep ahead of competitors ...

The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...

“Without access to diabetes educators who speak the same languages as our patients, diabetes-related education ... Abbott, Novo Nordisk, Eli Lilly and Company, Sanofi, and Insulet.

DelveInsight's Mild Cognitive Impairment Market Insights report includes a comprehensive understanding of current treatment ...

According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...